niclosamide has been researched along with Liver Neoplasms in 8 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
Liver Neoplasms: Tumors or cancer of the LIVER.
Excerpt | Relevance | Reference |
---|---|---|
"Niclosamide (NIC) is an anthelmintic agent repurposed as a potent anticancer agent." | 5.56 | Niclosamide-loaded polymeric micelles ameliorate hepatocellular carcinoma in vivo through targeting Wnt and Notch pathways. ( Abdel-Rahman, N; Eissa, LA; El-Karef, A; El-Sherbiny, IM; Yahia, S; Zeyada, MS, 2020) |
" Oral administration of NEN to mice significantly slowed growth of genetically induced liver tumors and patient-derived xenografts, whereas niclosamide did not, coinciding with the observed greater bioavailability of NEN compared with niclosamide." | 5.46 | Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling. ( Butte, AJ; Chen, B; Chua, MS; Gill, RM; Ma, L; So, S; Wei, W; Yang, B, 2017) |
"Niclosamide (NIC) is an anthelmintic agent repurposed as a potent anticancer agent." | 1.56 | Niclosamide-loaded polymeric micelles ameliorate hepatocellular carcinoma in vivo through targeting Wnt and Notch pathways. ( Abdel-Rahman, N; Eissa, LA; El-Karef, A; El-Sherbiny, IM; Yahia, S; Zeyada, MS, 2020) |
" Oral administration of NEN to mice significantly slowed growth of genetically induced liver tumors and patient-derived xenografts, whereas niclosamide did not, coinciding with the observed greater bioavailability of NEN compared with niclosamide." | 1.46 | Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling. ( Butte, AJ; Chen, B; Chua, MS; Gill, RM; Ma, L; So, S; Wei, W; Yang, B, 2017) |
"Hepatocellular carcinoma was then developed in the transgenic zebrafish." | 1.42 | Predominant Activation of JAK/STAT3 Pathway by Interleukin-6 Is Implicated in Hepatocarcinogenesis. ( Choi, JH; Chung, YY; Jung, IH; Lim, GL; Park, SW; Park, YN, 2015) |
"Metastasis formation in colon cancer severely reduces the survival rate in patients." | 1.37 | Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer. ( Fichtner, I; Kobelt, D; Lemm, M; Sack, U; Schlag, PM; Scudiero, D; Selby, M; Shoemaker, RH; Stein, U; Walther, W, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (87.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Zeyada, MS | 1 |
Abdel-Rahman, N | 1 |
El-Karef, A | 1 |
Yahia, S | 1 |
El-Sherbiny, IM | 1 |
Eissa, LA | 1 |
Alasadi, A | 1 |
Chen, M | 1 |
Swapna, GVT | 1 |
Tao, H | 1 |
Guo, J | 1 |
Collantes, J | 1 |
Fadhil, N | 1 |
Montelione, GT | 1 |
Jin, S | 1 |
Chien, MH | 1 |
Ho, YC | 1 |
Yang, SF | 1 |
Yang, YC | 1 |
Lai, SY | 1 |
Chen, WS | 1 |
Chen, MJ | 1 |
Yeh, CB | 1 |
Jung, IH | 1 |
Choi, JH | 1 |
Chung, YY | 1 |
Lim, GL | 1 |
Park, YN | 1 |
Park, SW | 1 |
Weng, S | 1 |
Zhou, L | 1 |
Deng, Q | 1 |
Wang, J | 1 |
Yu, Y | 1 |
Zhu, J | 1 |
Yuan, Y | 1 |
Chen, B | 1 |
Wei, W | 1 |
Ma, L | 1 |
Yang, B | 1 |
Gill, RM | 1 |
Chua, MS | 1 |
Butte, AJ | 1 |
So, S | 1 |
Helfman, DM | 1 |
Sack, U | 1 |
Walther, W | 1 |
Scudiero, D | 1 |
Selby, M | 1 |
Kobelt, D | 1 |
Lemm, M | 1 |
Fichtner, I | 1 |
Schlag, PM | 1 |
Shoemaker, RH | 1 |
Stein, U | 1 |
8 other studies available for niclosamide and Liver Neoplasms
Article | Year |
---|---|
Niclosamide-loaded polymeric micelles ameliorate hepatocellular carcinoma in vivo through targeting Wnt and Notch pathways.
Topics: Animals; Anthelmintics; Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Carriers; Liver Neopl | 2020 |
Effect of mitochondrial uncouplers niclosamide ethanolamine (NEN) and oxyclozanide on hepatic metastasis of colon cancer.
Topics: Animals; Antinematodal Agents; Colonic Neoplasms; Ethanolamine; Humans; Liver Neoplasms; Mice; Niclo | 2018 |
Niclosamide, an oral antihelmintic drug, exhibits antimetastatic activity in hepatocellular carcinoma cells through downregulating twist-mediated CD10 expression.
Topics: Administration, Oral; Anthelmintics; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Dow | 2018 |
Predominant Activation of JAK/STAT3 Pathway by Interleukin-6 Is Implicated in Hepatocarcinogenesis.
Topics: Aminopyridines; Animals; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Cyclic S-Oxides | 2015 |
Niclosamide induced cell apoptosis via upregulation of ATF3 and activation of PERK in Hepatocellular carcinoma cells.
Topics: Activating Transcription Factor 3; Activating Transcription Factor 4; Anthelmintics; Apoptosis; Carc | 2016 |
Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Ce | 2017 |
Niclosamide: an established antihelminthic drug as a potential therapy against S100A4-mediated metastatic colon tumors.
Topics: Animals; Anthelmintics; Antineoplastic Agents; beta Catenin; Biomarkers, Tumor; Cell Line, Tumor; Ce | 2011 |
Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
Topics: Animals; Anthelmintics; Antineoplastic Agents; beta Catenin; Biomarkers, Tumor; Cell Line, Tumor; Ce | 2011 |